Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

HUMA Humacyte, Inc. Common Stock
$0.74 3.69% +0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy HUMA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 200.7M
Enterprise value 183.3M
Trailing PE -2.8838462554491
Forward PE -3.1020832
PEG Ratio 0.021823701392588
Enterprise to EBITDA -1.742
Enterprise to revenue 90.9
Price to book MRQ 14.317307
Price to sales TTM 99.57619

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 2.0M
EBITDA -105185000
Diluted EPS TTM -0.65
Total Cash (MRQ) 48.5M
Current ratio (MRQ) 3.929
Operating Cash Flow (TTM) -101545000

HUMA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.